
HPGC Renmintongtai Pharmaceutical Corporation
SSE:600829.SS
8.41 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 10,048.279 | 10,389.98 | 9,641.093 | 9,315.236 | 8,005.26 | 8,353.884 | 7,055.221 | 8,008.881 | 9,005.559 | 8,909.315 | 1,738.795 | 3,177.005 | 4,068.385 | 3,605.739 | 3,005.089 | 2,638.253 | 2,594.344 | 2,268.208 | 2,064.448 | 1,768.996 | 642.704 | 511.723 | 503.24 | 521.118 | 516.97 | 385.945 | 352.811 | 307.88 | 264.773 | 264.305 | 276.459 | 309.283 | 246.994 | 174.604 | 167.929 |
Cost of Revenue
| 9,180.9 | 9,393.558 | 8,723.556 | 8,320.105 | 7,088.44 | 7,333.094 | 6,151.087 | 7,079.57 | 8,103.058 | 7,921.418 | 842.109 | 1,876.295 | 2,006.345 | 1,820.541 | 1,514.223 | 1,335.5 | 1,226.074 | 1,170.67 | 1,087.697 | 923.41 | 381.665 | 369.413 | 361.56 | 370.418 | 384.079 | 283.352 | 261.665 | 229.096 | 186.701 | 196.498 | 0 | 220.448 | 177.781 | 116.218 | 119.686 |
Gross Profit
| 867.379 | 996.422 | 917.537 | 995.13 | 916.819 | 1,020.791 | 904.134 | 929.311 | 902.501 | 987.897 | 896.686 | 1,300.71 | 2,062.041 | 1,785.198 | 1,490.865 | 1,302.753 | 1,368.27 | 1,097.538 | 976.751 | 845.586 | 261.039 | 142.31 | 141.68 | 150.7 | 132.891 | 102.593 | 91.146 | 78.784 | 78.072 | 67.806 | 276.459 | 88.834 | 69.213 | 58.386 | 48.243 |
Gross Profit Ratio
| 0.086 | 0.096 | 0.095 | 0.107 | 0.115 | 0.122 | 0.128 | 0.116 | 0.1 | 0.111 | 0.516 | 0.409 | 0.507 | 0.495 | 0.496 | 0.494 | 0.527 | 0.484 | 0.473 | 0.478 | 0.406 | 0.278 | 0.282 | 0.289 | 0.257 | 0.266 | 0.258 | 0.256 | 0.295 | 0.257 | 1 | 0.287 | 0.28 | 0.334 | 0.287 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.374 | 17.939 | 26.219 | 27.165 | 28.568 | 29.279 | 18.504 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 33.249 | 25.987 | 17.505 | 15.327 | 13.766 | 28.421 | 34.142 | 35.052 | 45.342 | 96.884 | 66.171 | 84.997 | 109.364 | 89.306 | 72.376 | 269.827 | 268.274 | 219.494 | 183.993 | 164.962 | 81.889 | 79.82 | 89.667 | 79.693 | 69.402 | 63.551 | 52.523 | 41.277 | 48.112 | 38.035 | 0 | 23.402 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 101.41 | 97.978 | 416.734 | 449.051 | 505.745 | 364.011 | 243.989 | 248.112 | 100.677 | 191.743 | 472.859 | 879.483 | 1,201.474 | 997.75 | 844.85 | 660.506 | 710.318 | 612.444 | 507.736 | 374.178 | 116.61 | 32.973 | 31.032 | 29.531 | 25.389 | 23.678 | 26.571 | 22.599 | 21.715 | 15.973 | 0 | 13.134 | 14.353 | 13.573 | 11.338 |
SG&A
| 134.659 | 544.01 | 434.239 | 464.378 | 519.51 | 392.433 | 278.131 | 283.163 | 146.019 | 288.627 | 539.03 | 964.48 | 1,310.838 | 1,087.056 | 917.226 | 930.333 | 978.592 | 831.938 | 691.729 | 539.14 | 198.499 | 112.793 | 120.699 | 109.224 | 94.79 | 87.229 | 79.094 | 63.876 | 69.826 | 54.008 | 0 | 36.536 | 14.353 | 13.573 | 11.338 |
Other Expenses
| 443.815 | 42.711 | 106.389 | 108.538 | 134.034 | 218.107 | 17.775 | 18.741 | 11.554 | 9.735 | -5.596 | 54.584 | 51.706 | 69.581 | 57.029 | 28.738 | 21.767 | 26.536 | -13.731 | -1.361 | 2.715 | 8.496 | 17.952 | 7.488 | 8.008 | -0.517 | 1.68 | 3.453 | 2.717 | -0.029 | 2.478 | -1.199 | -1.015 | -3.475 | 0.948 |
Operating Expenses
| 578.474 | 597.026 | 540.628 | 572.916 | 653.545 | 610.54 | 549.212 | 569.07 | 547.655 | 681.258 | 757.831 | 1,236.311 | 1,604.401 | 1,344.446 | 1,117.068 | 954.852 | 1,004.304 | 851.039 | 710.548 | 557.187 | 205.836 | 118.837 | 126.322 | 114.472 | 100.076 | 91.506 | 82.819 | 66.55 | 71.707 | 57.458 | 2.478 | 49.343 | 41.737 | 36.782 | 32.47 |
Operating Income
| 288.905 | 411.844 | 347.403 | 360.621 | 220.142 | 363.729 | 349.866 | 338.818 | 293.074 | 220.095 | 57.641 | 4.431 | 411.71 | 418.072 | 370.81 | 339.175 | 337.693 | 277.581 | 269.446 | 254.973 | 32.077 | 16.473 | 11.375 | 47.436 | 62.794 | 4.831 | 2.505 | 10.136 | 7.714 | 14.928 | 33.332 | 40.001 | 30.204 | 23.162 | 17.821 |
Operating Income Ratio
| 0.029 | 0.04 | 0.036 | 0.039 | 0.027 | 0.044 | 0.05 | 0.042 | 0.033 | 0.025 | 0.033 | 0.001 | 0.101 | 0.116 | 0.123 | 0.129 | 0.13 | 0.122 | 0.131 | 0.144 | 0.05 | 0.032 | 0.023 | 0.091 | 0.121 | 0.013 | 0.007 | 0.033 | 0.029 | 0.056 | 0.121 | 0.129 | 0.122 | 0.133 | 0.106 |
Total Other Income Expenses Net
| 0.153 | -18.458 | -1.846 | -2.017 | -0.445 | -2.464 | -4.152 | 1.054 | -20.327 | 9.286 | -2.18 | 51.862 | 48.807 | 67.452 | 49.275 | 20.178 | -9.917 | 26.434 | -17.25 | -36.891 | -14.209 | 8.012 | 9.483 | 6.406 | 7.33 | -0.659 | -6.829 | -0.138 | 3.553 | -0.077 | 2.478 | -2.32 | -3.743 | -5.033 | -1.1 |
Income Before Tax
| 289.058 | 393.386 | 345.557 | 358.605 | 219.697 | 361.265 | 345.713 | 339.872 | 302.601 | 229.381 | 51.946 | 56.293 | 460.517 | 485.524 | 420.085 | 360.764 | 354.049 | 304.015 | 253.401 | 252.56 | 37.893 | 24.485 | 20.858 | 53.842 | 70.124 | 4.171 | 3.418 | 9.998 | 11.267 | 14.852 | 35.81 | 37.681 | 26.461 | 18.129 | 16.722 |
Income Before Tax Ratio
| 0.029 | 0.038 | 0.036 | 0.038 | 0.027 | 0.043 | 0.049 | 0.042 | 0.034 | 0.026 | 0.03 | 0.018 | 0.113 | 0.135 | 0.14 | 0.137 | 0.136 | 0.134 | 0.123 | 0.143 | 0.059 | 0.048 | 0.041 | 0.103 | 0.136 | 0.011 | 0.01 | 0.032 | 0.043 | 0.056 | 0.13 | 0.122 | 0.107 | 0.104 | 0.1 |
Income Tax Expense
| 75.785 | 101.138 | 82.148 | 82.091 | 74.739 | 93.965 | 87.858 | 85.676 | 78.091 | 96.838 | 25.717 | 64.076 | 107.023 | 97.048 | 80.709 | 67.243 | 73.37 | 32.184 | 38.076 | 52.758 | -2.701 | 6.697 | 10.745 | 9.634 | 8.581 | 1.849 | 2.637 | 1.579 | 1.661 | 2.153 | 4.556 | 5.313 | 5.38 | 5.02 | 7.213 |
Net Income
| 213.272 | 292.162 | 264.478 | 277.296 | 145.264 | 267.335 | 257.859 | 254.196 | 224.51 | 138.916 | 39.851 | 6.462 | 363.973 | 398.595 | 333.818 | 278.786 | 269.281 | 268.085 | 218.245 | 145.127 | 26.693 | 17.789 | 10.112 | 44.208 | 61.543 | 2.323 | 0.781 | 8.419 | 9.606 | 12.699 | 31.254 | 30.415 | 21.082 | 13.109 | 9.509 |
Net Income Ratio
| 0.021 | 0.028 | 0.027 | 0.03 | 0.018 | 0.032 | 0.037 | 0.032 | 0.025 | 0.016 | 0.023 | 0.002 | 0.089 | 0.111 | 0.111 | 0.106 | 0.104 | 0.118 | 0.106 | 0.082 | 0.042 | 0.035 | 0.02 | 0.085 | 0.119 | 0.006 | 0.002 | 0.027 | 0.036 | 0.048 | 0.113 | 0.098 | 0.085 | 0.075 | 0.057 |
EPS
| 0.37 | 0.5 | 0.46 | 0.48 | 0.25 | 0.46 | 0.44 | 0.44 | 0.39 | 0.24 | 0.32 | 0.011 | 0.63 | 0.69 | 0.58 | 0.48 | 0.46 | 0.46 | 0.37 | 0.25 | 0.046 | 0.031 | 0.017 | 0.076 | 0.11 | 0.004 | -0.012 | 0.015 | 0.017 | 0.022 | 0.054 | 0.053 | 0.036 | 0.023 | 0.016 |
EPS Diluted
| 0.37 | 0.5 | 0.46 | 0.48 | 0.25 | 0.46 | 0.44 | 0.44 | 0.39 | 0.24 | 0.32 | 0.011 | 0.63 | 0.69 | 0.58 | 0.48 | 0.46 | 0.46 | 0.37 | 0.25 | 0.046 | 0.031 | 0.017 | 0.076 | 0.11 | 0.004 | -0.012 | 0.015 | 0.017 | 0.022 | 0.054 | 0.053 | 0.036 | 0.023 | 0.016 |
EBITDA
| 387.535 | 480.795 | 442.751 | 469.359 | 275.354 | 413.104 | 382.767 | 382.433 | 344.94 | 296.341 | 225.239 | 128.043 | 571.902 | 581.07 | 499.366 | 417.773 | 437.483 | 370.56 | 310.541 | 303.26 | 95.823 | 79.675 | 76.799 | 105.788 | 118.104 | 35.787 | 34.968 | 12.235 | 6.366 | 10.349 | 276.459 | 39.491 | 27.476 | 21.604 | 15.773 |
EBITDA Ratio
| 0.039 | 0.046 | 0.046 | 0.05 | 0.034 | 0.049 | 0.054 | 0.048 | 0.038 | 0.033 | 0.13 | 0.04 | 0.141 | 0.161 | 0.166 | 0.158 | 0.169 | 0.163 | 0.15 | 0.171 | 0.149 | 0.156 | 0.153 | 0.203 | 0.228 | 0.093 | 0.099 | 0.04 | 0.024 | 0.039 | 1 | 0.128 | 0.111 | 0.124 | 0.094 |